29 November 2016 | GENEVA – In advance of World AIDS Day, WHO has released new guidelines on HIV self-testing to improve access to and uptake of HIV diagnosis. According to a new WHO progress report lack of an HIV diagnosis is a major obstacle to ...

Drug use generally and chemsex more specifically are perceived to be common and normalised behaviours among gay men involved in those scenes in London, but this perception is contradicted by survey data. As social norms influence health-related behaviour, health promotion interventions should challenge the idea ...

Researchers have come up with the first direct evidence that enough hepatitis C virus (HCV) sheds into the rectums of HIV-positive men who have sex with men (MSM) to transmit directly to another man’s penis during anal sex, even when no blood is present. Publishing their ...

“Over the past 10 years, the number of officially recorded patients who receive HIV treatment in Russia has increased five fold from 7.5 % to 37% in 2015. This figure is expected to rise …to 41.5% this year, according to preliminary reports for 2016,” Skvortsova ...

Mylan signs sub-license agreement with the Medicines Patent Pool to increase access to hepatitis C treatment in developing countries HERTFORDSHIRE, England and BENGALURU, India, Nov. 28, 2016 — Mylan N.V. (NASDAQ, TASE: MYL) today announced that the company has signed an agreement with the Medicines Patent ...

A new WHO report provides insight into how countries in the WHO European Region can improve access and reduce medicine prices through strategic and well-planned procurement processes. The report examines the effect of different public procurement practices on supply security and prices for pharmaceuticals. It ...

South Africa hosts historic NIH-supported clinical trial The first HIV vaccine efficacy study to launch anywhere in seven years is now testing whether an experimental vaccine regimen safely prevents HIV infection among South African adults. The study, called HVTN 702, involves a new version of the ...

Strengthened global political commitment to HIV prevention must be followed by strengthened financial commitment. The successes of the global AIDS response to date have been fuelled by extraordinary investment. The total amount of financial resources for AIDS responses in low- and middle-income countries reached an ...

Getting ready for World AIDS Day, the European Centre for Disease Prevention and Control (ECDC) has published the HIV testing guidance evaluation technical report, now released on ECDC website ahead of December 1st: http://ecdc.europa.eu/en/publications/Publications/HIV-testing-guidance-evaluation.pdf This document was developed with considerable input from members of the PLHIV ...

Research carried out by Mount Sinai Medical Center, New York, found that non-adherence was the strongest risk factor for treatment failure in people taking sofosbuvir/ledipasvir (Harvoni). The main reasons cited for non-adherence were failing to take medication as prescribed and hospitalisation. The findings were presented at ...

1 December 2016 Michel Sidibé, Executive Director of UNAIDS, Under-Secretary-General of the United Nations Today, we commemorate World AIDS Day—we stand in solidarity with the 78 million people who have become infected with HIV and remember the 35 million who have died from AIDS-related illnesses since the ...

Dorthe Raben has been working in the HIV/AIDS field for many years. Her work with HIV in Europe and OptTEST encompasses the scientific and policy aspects of testing, linkage to care and prevention in HIV/AIDS. In this interview she speaks about results and challenges. Original Article

“I had no idea that since I have HIV, I may be twice as likely to have a heart event compared to the general population,” said Frank Carroll, a 63-year-old man who has been living with HIV for over two decades. Unfortunately, that is the case ...

Rosuvastatin for 96 weeks significantly slowed progression of subclinical atherosclerosis — as measured by common carotid artery intima-media thickness (CCA-IMT) — in a double-blind placebo-controlled trial. Participants had normal low-density lipoprotein cholesterol (LDL-C) before treatment began, but the statin further lowered LDL-C, according to the ...

Apathy and political expedience have shaped the Kremlin’s frozen-in-time views on the virus. Will officials finally act to prevent a national health crisis? Moscow, November 22, 2016 — Max Malyshev first started using drugs as a teenager in Tver, an industrial city north of Moscow, mostly ...

A triple regimen based on an integrase inhibitor decreases viral load in semen very quickly, reducing transmission risk More than 2 million people got infected by human immunodeficiency virus (HIV) in 2015, being sexual transmission the main channel of infection. Researchers from the Infections of the ...

Who has hepatitis? Well, that’s a good question. We know that some groups are more likely to acquire HCV infection than others. But, unfortunately, most people who have the virus have not yet been diagnosed. November 2016 marks the fourth European Testing Week – and the ...

From 18 to 25 November 2016, almost 500 organisations all across Europe are hosting activities to increase awareness of the benefits of HIV and hepatitis testing. These diseases can be asymptomatic for a long time and without getting tested, many people will live with their ...